Pfizer (PFE) Restructuring Costs (2009 - 2026)
Pfizer (PFE) reported Restructuring Costs of $457 million for Q2 2026, compared with -$74 million a year earlier and up 357.0% from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) Restructuring Costs (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 28, 2026, Pfizer's Restructuring Costs came in at $1.45 billion, down 13.1% year-over-year; for FY2025, it came in at $1.55 billion, down 35.9% from FY2024.
- Restructuring Costs has a five-year compound annual growth rate of 21.8% (FY2020 to FY2025).
- By year, Restructuring Costs came in at $2.42 billion in FY2024 (-17.8%), $2.94 billion in FY2023 (+114.0%), $1.38 billion in FY2022 (+71.4%) and $802 million in FY2021 (+38.5%).
- Five-year quarterly Restructuring Costs spans a low of -$74 million in Q2 2025 and a high of $2.57 billion in Q4 2023.
- Year over year, Restructuring Costs gained in 1 of the last five quarters, with growth averaging 76.1%.
- The high point for year-over-year Restructuring Costs in five years was Q1 2022 (growth of 772.7%); the low point was Q1 2026 (a decline of 85.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $100 million (Q1 2026), $605 million (Q4 2025) and $286 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 130.49 Bn | 81.76 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 457.00 Mn |
| Mar 29, 2026 | 100.00 Mn |
| Dec 31, 2025 | 605.00 Mn |
| Sep 28, 2025 | 286.00 Mn |
| Jun 29, 2025 | -74.00 Mn |
| Mar 30, 2025 | 678.00 Mn |
| Dec 31, 2024 | 750.00 Mn |
| Sep 29, 2024 | 313.00 Mn |
| Jun 30, 2024 | 1.25 Bn |
| Mar 31, 2024 | 102.00 Mn |
| Dec 31, 2023 | 2.57 Bn |
| Jul 2, 2023 | 214.00 Mn |
| Apr 2, 2023 | -44.00 Mn |
| Dec 31, 2022 | 795.00 Mn |
| Jul 3, 2022 | 189.00 Mn |
| Apr 3, 2022 | 192.00 Mn |
| Dec 31, 2021 | 135.00 Mn |
| Oct 3, 2021 | 646.00 Mn |
| Jul 4, 2021 | -5.00 Mn |
| Apr 4, 2021 | 22.00 Mn |
API Access
Pfizer Restructuring Costs API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=restructuring-costs&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "restructuring-costs", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=restructuring-costs&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();